Medicines

General information about medicines, as well as advice on safety information, medicines and pregnancy, and medicine shortages.

Medicines pages

How we regulate medicines

20 June 2019

Reference material

Learn how your medicines are regulated in Australia.
Find information about a medicine

Page

Search for medicines allowed to be supplied in Australia, medicine ingredients and safety information.
How we regulate

Section

Find out how to get a medicine or medical device into the ARTG so you can legally sell it in Australia.

More information

Dispose of unwanted medicines

Safe disposal of unwanted medicines

Health professionals

University student education materials

Medicines

Latest alerts

Further shortage of methylphenidate hydrochloride products

8 April 2025

Medicine shortage alerts

Ritalin and Artige immediate-release tablets are now also in shortage, and a shortage of Ritalin LA capsules is anticipated.
Isotretinoin (Roaccutane)

7 April 2025

Safety alerts

Acne medication warnings further highlight potential risks of mood-related changes and sexual disorders.
NAD, NAD+, NADH or NMN medicines sold in Australia

7 April 2025

Safety alerts

We are aware of products being sold in Australia that claim to contain, or influence the levels of, nicotinamide adenine dinucleotide (NAD, NAD+, NADH) or nicotinamide mononucleotide (NMN) in the body.

Latest articles

Listed medicines requiring a warning statement

9 April 2025

News

We will be initiating targeted compliance reviews of selected listed medicines that are required to display a warning statement
Enforceable undertaking: Your Solution Compounding Pharmacy

7 April 2025

Compliance undertakings

We have accepted a court-enforceable undertaking from Your Solution Compounding Pharmacy Pty Ltd, regarding advertising of prescription-only compounded medicines for weight-loss.
Your Solution Compounding Pharmacy undertakes to comply with advertising rules for weight-loss medicines

7 April 2025

Media releases

We have accepted a court-enforceable undertaking from Your Solution Compounding Pharmacy Pty Ltd, regarding advertising of prescription-only compounded medicines for weight-loss.

Events and webinars

Q&A session in relation to new guidance material ‘Demonstrating the quality of listed probiotic medicines’

30 April 2025

Webinars

This is a Q&A Session for Industry about the recently published guidance on listed probiotic medicines.
Insights into Good Clinical Practice (GCP) Inspection Program activities 2023-2024

9 May 2025

Webinars

This webinar provides an overview of TGA’s Good Clinical Practice (GCP) Inspection Program clinical trial compliance activities.

Latest publications

2025 Seasonal influenza vaccines

15 April 2025

Publications

Find out about the seasonal influenza vaccines available for the 2025 southern hemisphere season.
Notice of interim decisions on proposed amendments to the Poisons Standard - ACMS #46 and Joint ACMS-ACCS #38 - November 2024

14 March 2025

Scheduling decisions (interim)

Interim decisions on proposed amendments to the Poisons Standard closing 4 April 2025
ACM meeting statement, Meeting 49, 6 and 7 February 2025

13 March 2025

Meeting statements

Advisory Committee on Medicines meeting statement

Latest consultations

Consultation: Proposed amendments to the Poisons Standard – ACCS and Joint ACMS-ACCS meetings – March 2025

Closed on 17 February 2025

Consultation

Have your say about proposals to amend the Poisons Standard. These will be considered at the next meeting of the Advisory Committee on Chemicals Scheduling (ACCS) and joint meeting of the Advisory Committee on Medicines Scheduling (ACMS) and ACCS.
Consultation: Adoption of International Scientific Guidelines in Australia R01-2024

Closed on 16 January 2025

Consultation

We are seeking feedback on whether 19 international scientific guidelines should be adopted.
Consultation: Medicine shortages and discontinuations - Reportable medicines and timeframes for reporting discontinuations

Closed on 13 January 2025

Consultation

We are seeking feedback on proposed improvements to TGA’s regulatory framework for medicine shortages and discontinuations in Australia.

Sub menu

Medicines

Medicines pages

How we regulate medicines

Find information about a medicine

How we regulate

Prescription medicines

Non-prescription medicines

Biological medicines

Vaccines

Sunscreens

Weight loss products

More information

Dispose of unwanted medicines

Health professionals

University student education materials

Latest alerts

Further shortage of methylphenidate hydrochloride products

Isotretinoin (Roaccutane)

NAD, NAD+, NADH or NMN medicines sold in Australia

Latest articles

Listed medicines requiring a warning statement

Enforceable undertaking: Your Solution Compounding Pharmacy

Your Solution Compounding Pharmacy undertakes to comply with advertising rules for weight-loss medicines

Events and webinars

Q&A session in relation to new guidance material ‘Demonstrating the quality of listed probiotic medicines’

Insights into Good Clinical Practice (GCP) Inspection Program activities 2023-2024

Latest publications

2025 Seasonal influenza vaccines

Notice of interim decisions on proposed amendments to the Poisons Standard - ACMS #46 and Joint ACMS-ACCS #38 - November 2024

ACM meeting statement, Meeting 49, 6 and 7 February 2025

Latest consultations

Consultation: Proposed amendments to the Poisons Standard – ACCS and Joint ACMS-ACCS meetings – March 2025

Consultation: Adoption of International Scientific Guidelines in Australia R01-2024

Consultation: Medicine shortages and discontinuations - Reportable medicines and timeframes for reporting discontinuations

Help us improve this page

Site notifications

Medicines

Medicines pages

Prescription medicines

Non-prescription medicines

Biological medicines

Vaccines

Sunscreens

Weight loss products

More information

Dispose of unwanted medicines

Health professionals

University student education materials

Latest alerts

Latest articles

Events and webinars

Latest publications

Latest consultations

Help us improve this page